Squalene biosynthesis pathway

The "Squalene biosynthesis pathway" refers to a segment of the broader sterol/cholesterol biosynthetic process. **Squalene** is a natural triterpene compound that serves as an essential intermediate in the endogenous production of cholesterol and other sterols. The key enzyme for its formation is **squalene synthase**, which catalyzes the conversion of farnesyl pyrophosphate to squalene within the mevalonate pathway. This step occurs downstream from HMG-CoA reductase, which is targeted by statin drugs for lowering blood cholesterol. **Amaranth seed oil** is notable for its exceptionally high content of dietary squalene—higher than most plant or animal sources—which has led to interest in its use as a functional food ingredient or nutraceutical supplement[1][2][4]. Dietary intake of squalene from amaranth oil has been shown in animal studies to lower serum and liver lipid levels, possibly by increasing fecal excretion of steroids and slightly inhibiting HMG-CoA reductase activity, though results are source-dependent and sometimes controversial[3]. Phytosterols present alongside squalene may also contribute synergistically to hypocholesterolemic effects. While individual enzymes within this metabolic route—such as **HMG-CoA reductase** or **squalene synthase**—are established therapeutic targets, especially for hypercholesterolemia, the "squalene biosynthesis pathway" itself is not considered a single molecular target but rather a collection of enzymatic steps. Thus, it does not fit standard definitions for druggable targets like receptors or enzymes. In summary: > The "Squalene biosynthesis pathway modulation by dietary squalene/phytosterols from amaranth seed oil" describes nutritional intervention at multiple points within sterol metabolism rather than targeting one specific molecule or receptor. While components such as HMG-CoA reductase are validated drug targets, the entire metabolic sequence ("pathway") should not be classified as a single therapeutic target.[1][3][5] If you need structured information on specific enzymes within this route (e.g., "HMG-CoA reductase," "Squalene synthase"), please specify which enzyme/target you wish to focus on.

Other names

Squalene synthesis pathwayCholesterol biosynthesis pathway (partial overlap)Mevalonate pathway (upstream)

Inhibition of HMG-CoA reductase reduces squalene and cholesterol synthesis[3][5]